The rise of drug-resistant pathogens is an evolving problem impacting millions of patients around the world. 
In this webinar 
How Ares Genetics uses a novel capture-based next-generation sequencing assay and AI-assisted bioinformatics solutions to capture the microbial resistome of key human pathogens directly from native specimen. 
How the assay offers comprehensive and sensitive screening for over 7000 AMR markers and provides an opportunity to enable machine learning-based predictive susceptibility testing via the captured resistome. 
Discussion of assay evaluation on synovial fluids and urine specimen, with initial findings encouraging further exploration and expansion into additional specimen types.